Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
D Jan 20, 2023
4/A Jan 19, 2023 FORM 4/A SUBMISSION
8-K Jan 19, 2023 CURRENT REPORT
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
4 Jan 17, 2023 FORM 4 SUBMISSION
8-K Dec 12, 2022 FORM 8-K
4 Dec 1, 2022 FORM 4 SUBMISSION
8-K Nov 15, 2022 CURRENT REPORT
10-Q Nov 14, 2022 10-Q
SC 13D/A Nov 9, 2022 AMENDMENT NO. 5 TO SCHEDULE 13D
4 Nov 3, 2022 FORM 4 SUBMISSION
4 Oct 31, 2022 FORM 4 SUBMISSION
DEF 14A Oct 31, 2022 FORM DEF 14A
4 Oct 24, 2022 FORM 4 SUBMISSION
PRE 14A Oct 21, 2022 PRE 14A
4 Oct 19, 2022 FORM 4 SUBMISSION
4 Oct 17, 2022 FORM 4 SUBMISSION
4 Oct 13, 2022 FORM 4 SUBMISSION
4 Oct 12, 2022 FORM 4 SUBMISSION
← Newer Page 4 of 50 · 1238 filings Older →